A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound. One of its ...

As tough as it may be to do right now, this is a great time to hold your nose and dive in while yields are as high as they are.

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Shares in pharmaceuticals firm Eli Lilly (LLY) ballooned higher today after revealing its new needle-free weight loss drug had performed ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

President Donald Trump has ordered the Department of Health and Human Services to standardize Medicare payments in an effort ...

Pfizer has stopped the development of its weight loss pill after a patient experienced a liver injury that was potentially ...

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

Pfizer just pulled the plug on its oral weight-loss pill danuglipron after a liver injury case raised safety alarms. This decision underscores how the path from lab to medicine cabinet is riddled with ...

President Donald Trump signed an executive order on the healthcare sector yesterday, aiming to lower prescription drug prices ...